These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4362107)

  • 21. [Fibrin pleurodesis in malignant pleural effusions].
    Kreuser ED; Seifried E; Harsch U; Brass B; Schreml W; Heimpel H
    Dtsch Med Wochenschr; 1985 Sep; 110(36):1365-8. PubMed ID: 2411490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleural and pericardial effusions in cancer patients.
    McKenna RJ; Ali MK; Ewer MS; Frazier OH
    Curr Probl Cancer; 1985 Jun; 9(6):1-44. PubMed ID: 3896666
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrapleural tetracycline for control of malignant pleural effusion: a preliminary report.
    Rubinson RM; Bolooki H
    South Med J; 1972 Jul; 65(7):847-9. PubMed ID: 5038178
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Treatment for malignant pleural effusions.
    Bezanilla AR
    Chest; 1976 Sep; 70(03):408-9. PubMed ID: 954477
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the pathology and clinical picture of tumor endocarditis].
    Stosiek P
    Dtsch Med Wochenschr; 1969 Apr; 94(17):908-11. PubMed ID: 5778747
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thoracoscopic talc poudrage in pleurisies of blood diseases].
    Viallat JR; Tubiana N; Boutin C; Farisse P; Lejeune C; Carcassonne Y
    Nouv Rev Fr Hematol (1978); 1986; 28(6):381-5. PubMed ID: 3562222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for pleurectomy in malignant effusion.
    Martini N; Bains MS; Beattie EJ
    Cancer; 1975 Mar; 35(3):734-8. PubMed ID: 1111941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased glucose concentration in malignant pleural effusions.
    Berger HW; Maher G
    Am Rev Respir Dis; 1971 Mar; 103(3):427-9. PubMed ID: 5152727
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pleuroperitoneal shunt for malignant pleural effusions].
    Sadahiro S; Tsumura O; Kubouchi K; Isobe Y; Ohmura T; Yamada Y; Saito T; Takeguchi K
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):1-6. PubMed ID: 2738435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleural peritoneal shunts for the treatment of malignant pleural effusions.
    Weese JL; Schouten JT
    Surg Gynecol Obstet; 1982 Mar; 154(3):391-2. PubMed ID: 7064076
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical contribution to the study of the association of leukemias and malignant neoplasms].
    Di Paolo N; Marcolongo R; Carcassi A; Bianco G; Bravi A; Lunghetti R; Tuveri A; Quattrini L
    Cancro; 1968; 21(5):443-68. PubMed ID: 4901501
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
    Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
    Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correctable complications of neoplastic disease. 3. Neoplastic effusions.
    Farber LR
    Conn Med; 1971 Jun; 35(6):411-2. PubMed ID: 5165442
    [No Abstract]   [Full Text] [Related]  

  • 35. [Intrapleural thiotepa for malignant pleural effusions (author's transl)].
    Lee CM; Huang WC
    Taiwan Yi Xue Hui Za Zhi; 1982 Jan; 81(1):108-11. PubMed ID: 6808081
    [No Abstract]   [Full Text] [Related]  

  • 36. Elevated sialyl Lewis X-i antigen levels in pleural effusions in patients with carcinomatous pleuritis.
    Ishikawa H; Satoh H; Kamma H; Naito T; Yamashita YT; Ohtsuka M; Hasegawa S
    Intern Med; 1997 Oct; 36(10):685-9. PubMed ID: 9372327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The course and prognosis in some types of carcinomatous neuromyopathy.
    Croft PB; Wilkinson M
    Brain; 1969 Mar; 92(1):1-8. PubMed ID: 4304423
    [No Abstract]   [Full Text] [Related]  

  • 38. INTRAPLEURAL MECHLORETHAMINE HYDROCHLORIDE THERAPY FOR MALIGNANT PLEURAL EFFUSION.
    MARK JB; GOLDENBERG IS; MONTAGUE AC
    JAMA; 1964 Mar; 187():858-60. PubMed ID: 14094329
    [No Abstract]   [Full Text] [Related]  

  • 39. [Malignant tumors associated with ovarian carcinoma. Study of 13 cases].
    Bolis PF; Franchi M; Guaschino S; Pesando PC
    Minerva Ginecol; 1982 May; 34(5):355-62. PubMed ID: 6290947
    [No Abstract]   [Full Text] [Related]  

  • 40. A case report of four primary cancers: larynx, breast, kidney, and uterus.
    Parsa C
    J Am Osteopath Assoc; 1975 Jan; 74(5):411-6. PubMed ID: 162916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.